Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511212
Status:
WITHDRAWN
Last Update Posted:
2011-07-21
First Post:
2007-08-01
Brief Title:
Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract
Sponsor:
Multicenter Clinical Study Group of Osaka Colorectal Cancer Treatment Group
Organization:
Multicenter Clinical Study Group of Osaka Colorectal Cancer Treatment Group
Study Overview
Official Title:
Clinical Study of Intravenous Immunoglobulin IVIG in Combination Therapy With Antibacterial Agents for Surgical Site Infection of the Lower Digestive Tract
Status:
WITHDRAWN
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No eligible patient
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the clinical usefulness of IVIG in combination therapy with antibacterial agents for severe peritonitis after lower digestive tract surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None